Sensient Technologies

Recent news

• UBS Maintains Sensient Technologies(SXT.US) With Buy Rating, Maintains Target Price $143
  Market Newswire · 2026/7/6
• UBS Maintains Sensient Technologies(SXT.US) With Buy Rating, Raises Target Price to $157
  Market Newswire · 2026/9/30
• Rating change
  Baird Maintains Sensient Technologies(SXT.US) With Buy Rating, Raises Target Price to $125
  Market Newswire · 2025/7/4
• Company notice
  China SXT Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Streeterville Capital LLC(9.99*%),Streeterville Management LLC(9.99*%), etc.
  SEC · 2023/3/30
• Company notice
  China SXT Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Streeterville Capital LLC(9.99*%),Streeterville Management LLC(9.99*%), etc.
  SEC · 2022/8/26
• Baird Maintains Sensient Technologies(SXT.US) With Buy Rating, Announces Target Price $140
  Market Newswire · 2026/7/27
• Company notice
  China SXT Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Streeterville Capital LLC(0%),Streeterville Management LLC(0%), etc.
  SEC · 2023/3/30
• Rothschild & Co Redburn Initiates Sensient Technologies(SXT.US) With Hold Rating, Announces Target Price $125
  Market Newswire · 2026/7/8
• Company notice
  China SXT Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Streeterville Capital LLC(9.99%),Streeterville Management LLC(9.99%), etc.
  SEC · 2024/10/26
• Rating change
  Baird Maintains Sensient Technologies(SXT.US) With Buy Rating, Raises Target Price to $93
  Market Newswire · 2025/4/29
• Rating change
  Baird: Maintaining the Sensient Technologies (SXT.US) rating, adjusted from better than market to better than market rating, and adjusted the target price from $70.00 to $80.00.
  Zhitong Finance · 2024/4/29
• Company notice
  China SXT Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Lind Global Fund II LP(9.9%),Lind Global Fund II LLC(9.9%), etc.
  SEC · 2022/1/22
• Rating change
  Baird Maintains Sensient Technologies(SXT.US) With Buy Rating, Maintains Target Price $85
  Market Newswire · 2024/10/28
• Rating change
  Baird Maintains Sensient Technologies(SXT.US) With Buy Rating, Raises Target Price to $85
  Market Newswire · 2024/7/29
• UBS Maintains Sensient Technologies(SXT.US) With Buy Rating, Raises Target Price to $155
  Market Newswire · 2026/7/27
• Rating change
  UBS Initiates Sensient Technologies(SXT.US) With Buy Rating, Announces Target Price $115
  Market Newswire · 2026/4/1
• Rating change
  UBS Maintains Sensient Technologies(SXT.US) With Buy Rating, Raises Target Price to $143
  Market Newswire · 2026/4/28

Headlines are aggregated automatically and are not independently verified or edited by our team.